Почетна › Астма › Пенсилванија
Kliničke studije za Астма u državi Пенсилванија
12 studija za Астма traži učesnike na lokacijama u državi Пенсилванија.
Gradovi u državi Пенсилванија
Zvanični tekst studije (na engleskom)
A Study to Investigate the Efficacy and Safety of GSK5784283 Compared With Placebo in Participants With Uncontrolled Asthma (PERSIST ASTHMA-2)
- GSK Investigational Site, DuBois
- GSK Investigational Site, Philadelphia
Тражи се учесникФаза 3
Узраст од 12 до 80 · Оба пола · Ажурирано 12. 11. 2026. · NCT07782996Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
- Research Site, Pittsburgh
Тражи се учесникФаза 3
Узраст од 12 до 17 · Оба пола · Ажурирано 10. 11. 2026. · NCT06307665A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate-To-Severe Asthma
- Clinical Research Associates of Central PA, LLC, DuBois
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 6. 11. 2026. · NCT06977581A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
- University of Pittsburgh Medical Center, Pittsburgh
- Allergy and Clinical Immunology Associates, Pittsburgh
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 5. 11. 2026. · NCT07219173A Study to Learn About the Study Medicine Called Tilrekimig ( PF-07275315) in People With Severe Asthma
- Allergy and Clinical Immunology Associates, Pittsburgh
Тражи се учесникФаза 3
Узраст од 12 до 80 · Оба пола · Ажурирано 5. 11. 2026. · NCT07869043Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids
- Research Site, Philadelphia
- Research Site, Smithfield
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 30. 10. 2026. · NCT06932263Acoustic Waveform Respiratory Evaluation
- University of Pittsburgh, Pittsburgh
Тражи се учесникЗдраве особе су добродошле
Узраст од 8 до 70 · Оба пола · Ажурирано 5. 10. 2026. · NCT06512064A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma
- GSK Investigational Site, DuBois
- GSK Investigational Site, Wyomissing
Тражи се учесникФаза 3
Узраст 12 и старији · Оба пола · Ажурирано 17. 8. 2026. · NCT07456033Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
- The University of Pittsburgh Asthma Institute at UPMC, Pittsburgh
Тражи се учесникФаза 4
Узраст 18 и старији · Оба пола · Ажурирано 6. 8. 2026. · NCT04743791A Clinical Study to Evaluate the Efficacy and Safety of Frevecitinib (KN-002) in Patients With Severe Asthma
- Research site, Pittsburgh
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 28. 7. 2026. · NCT07532265A Study of CDX-622 in Participants With Mild to Moderate Asthma
- University of Pittsburgh Asthma and Environmental Lung Health Institute at UPMC, Pittsburgh
Тражи се учесникФаза 1
Узраст 18 и старији · Оба пола · Ажурирано 2. 7. 2026. · NCT07330778Depemokimab Asthma Imaging and Bronchoscopy Sub-Study
- GSK Investigational Site, DuBois
- GSK Investigational Site, Philadelphia
Тражи се учесникФаза 3
Узраст 18 и старији · Оба пола · Ажурирано 2. 7. 2026. · NCT06979323Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.